A Novel and Evolutionarily Conserved Metabolic Axis for Efficient Hepatic Lipid Catabolism Governed by Mfn2-Hsl-Mediated Mitochondria-Lipid Droplet Coupling

Researchers have unveiled a novel and evolutionarily conserved metabolic axis that efficiently regulates hepatic lipid catabolism via a mitochondria-LD coupling mechanism. This intricate inter-organelle relationship between mitochondria and lipid droplets (LDs) in the liver has long been a mystery, but a new study sheds light on the underlying tethering complex responsible for this interaction.

Using hepatocyte models from various species and in vivo experiments on yellow catfish fed with distinct lipid and creatine diets, scientists meticulously explored the mechanism and evolutionary conservation of mitochondria-LD coupling. The key findings revealed several critical insights:

Firstly, the study identified a novel complex comprised of mitofusin 2 (Mfn2) on mitochondria and hormone-sensitive lipase (HSL) on lipid droplets. This complex, mediated by specific residues, orchestrates efficient hepatic lipid catabolism by coupling mitochondria and LDs. This groundbreaking discovery provides a new understanding of the molecular machinery responsible for this crucial metabolic process.

Secondly, the researchers discovered that creatine supplementation enhances the mitochondria-LD coupling axis by upregulating Mfn2 expression through the transcription factor hepatocyte nuclear factor 4 alpha (HNF4). This upregulation promotes the formation of peridroplet mitochondria within the LDs, thereby alleviating hepatic lipid accumulation. This finding suggests that creatine supplementation could potentially alleviate hepatic steatosis, a condition characterized by excessive fat storage in the liver.

Lastly, the study established that the Mfn2-phosphorylated HSL axis is evolutionarily conserved across a wide range of species, including fish and mammals. This conservation of the metabolic axis across diverse organisms highlights its fundamental role in hepatic lipid homeostasis and suggests that targeting this axis may offer a promising therapeutic approach for managing hepatic steatosis.

In conclusion, this groundbreaking research has unveiled a novel and evolutionarily conserved metabolic axis governing efficient hepatic lipid catabolism through mitochondria-LD coupling. The identification of the Mfn2-HSL-mediated complex and the discovery of creatine's role in enhancing this coupling provide valuable insights into the regulation of hepatic lipid homeostasis.

Furthermore, the conserved nature of this axis across species opens up exciting possibilities for developing targeted therapies to combat hepatic steatosis and other related metabolic disorders.